Skip to main content

EVOTEC SE (EVOTF) Stock

EVOTEC SE Stock Details, Movements and Public Alerts

Stock Details

EVOTEC SE (EVOTF), a prominent company in the healthcare sector within the drug manufacturers - specialty & generic industry, is based in Germany and primarily trades on the PNK.Currently, the stock is trading at $8.01. Over the past 52 weeks, it has ranged between $7.05 and $9.85. This places the current price at 81.3% of its 52-week high and 13.6% above its 52-week low. 0The 14-day Relative Strength Index (RSI) stands at 34.28, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $7.45 by 7.52%. Similarly, it is below its 200-day moving average of $8.15 by 1.72%. The MACD histogram is 0.02, indicating bullish momentum (MACD Line: -0.03, Signal Line: -0.05).

52-Week Range

$9.85 - $7.05

-18.68% from high · +13.62% from low

Avg Daily Volume

N/A

100-day average

0

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Price to Book

1.52

EV/EBITDA

128499.09

EPS (TTM)

-$1.05

Price to Sales

1.88

Beta

1.15

Similar volatility to market

How is EVOTF valued relative to its earnings and growth?
Valuation data is not available for this stock.
What is EVOTF's risk profile compared to the market?
With a beta of 1.15, EVOTEC SE is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility. The price-to-book ratio of 1.52 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

-21.02%

Operating Margin

-26.60%

EBITDA

$13,000

Return on Equity

-17.98%

Return on Assets

-2.69%

Revenue Growth (YoY)

-11.40%

How profitable and efficient is EVOTF's business model?
EVOTEC SE achieves a profit margin of -21.02%, meaning it retains $-21.02 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of -26.60% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -17.98% and ROA at -2.69%, the company achieves moderate returns on invested capital.
What are EVOTF's recent growth trends?
EVOTEC SE's revenue declined by 11.40% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions. These growth metrics should be evaluated against Drug Manufacturers - Specialty & Generic industry averages for proper context.

Company Size & Market

Market Cap

$1.4B

Revenue (TTM)

$756.33M

Revenue/Share (TTM)

$4.26

Shares Outstanding

177.60M

Book Value/Share

$5.29

Asset Type

EQUITY

What is EVOTF's market capitalization and position?
EVOTEC SE has a market capitalization of $1.4B, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 177.60M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Drug Manufacturers - Specialty & Generic industry, it competes with other firms in this sector.
How does EVOTF's price compare to its book value?
EVOTEC SE's book value per share is $5.29, while the current stock price is $8.01, resulting in a price-to-book (P/B) ratio of 1.52. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As EQUITY, this represents a specific type of security.

Fundamentals last updated: Dec 13, 2025, 08:26 AM

Technical Indicators

RSI (14-day)

34.28

Neutral

50-Day Moving Average

$7.45

7.52% above MA-50

200-Day Moving Average

$8.15

-1.72% below MA-200

MACD Line

-0.03

MACD Signal

-0.05

MACD Histogram

0.02

Bullish

What does EVOTF's RSI value tell investors?
The RSI (Relative Strength Index) for EVOTF is currently 34.28, indicating the stock is showing bearish momentum (30-40 range). Selling pressure is evident but not extreme. This often occurs during pullbacks in uptrends or early stages of downtrends. Combined with the price being above the 50-day moving average, this shows mixed signals requiring careful analysis.
How should traders interpret EVOTF's MACD and moving average crossovers?
MACD analysis shows the MACD line at -0.03 above the signal line at -0.05, with histogram at 0.02. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($7.45) is below the 200-day MA ($8.15), forming a death cross pattern that often warns of extended weakness. Price is currently between the MAs, suggesting transition.

Indicators last updated: Oct 18, 2025, 12:46 AM

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for EVOTF and get notified when the price changes.

Stay Ahead of the Market with EVOTEC SE Alerts

Set up price alerts for EVOTEC SE and get notified instantly when the price hits your target. Never miss an important price movement again.